The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Evaluation of Two Live, Cold‐Passaged, Temperature‐Sensitive Respiratory Syncytial Virus Vaccines in Chimpanzees and in Human Adults, Infants, and Children
Open accessAbstract
Two live-attenuated, cold-passaged (cp), temperature-sensitive (ts) candidate vaccines, designated cpts530/1009 and cpts248/955, were attenuated, genetically stable, and immunogenic in chimpanzees and were highly attenuated for human adults. In respiratory syncytial virus (RSV)-seropositive children, cpts530/1009 was more restricted in replication than cpts248/955. In seronegative children, 10(4) pfu of cpts248/955 was insufficiently attenuated, and a high titer of vaccine virus was shed (mean peak titer, 10(4.4) pfu/mL), whereas 10(4) pfu of cpts530/1009 was relatively attenuated and restricted in replication (mean peak titer, 10(2.0) pfu/mL). At a dose of 10(5) pfu, cpts530/1009 was immunogenic in seronegative children (geometric mean titer of RSV neutralizing antibodies, 1:724). Transmission of either vaccine to seronegative placebo recipients occurred at a frequency of 20%-25%. Of importance, vaccine viruses recovered from chimpanzees and humans were ts. In contrast to previous studies, this study indicates that live attenuated RSV vaccines that are immunogenic and phenotypically stable can be developed. Additional studies are being conducted to identify a live RSV vaccine that is slightly more attenuated and less transmissible than cpts530/1009.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KIM, H. W., CANCHOLA, J. G., BRANDT, C. D., PYLES, G., CHANOCK, R. M., JENSEN, K., & PARROTT, R. H. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120955 · Cited by 1,981
Groothuis, J. R., Simoes, E., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292102 · Cited by 744 · cited 1×
“The geometric mean titers of RSV neutralizing antibody achieved in recipients of 104 pfu of the 248Z955 vaccine (1:776) and of 105 pfu of 530Z1009 vaccine (1:724) were well above the level believed necessary to protect the lower respiratory tracts of susceptible infants [37].”
Background
Cited by
Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996
Shay, D. K. (1999) · JAMA · doi:10.1001/jama.282.15.1440 · Cited by 1,385
Respiratory Syncytial Virus and Parainfluenza Virus
Hall, C. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442507 · Cited by 1,233
Respiratory syncytial virus infection
Simoes, E. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)80040-3 · Cited by 603
Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis Media
Heikkinen, T., Thint, M., & Chonmaitree, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400402 · Cited by 524
Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis
Collins, P. L., & Graham, B. S. (2008) · Journal of Virology · doi:10.1128/jvi.01625-07 · Cited by 486
Collins, P. L., & Melero, J. A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.020 · Cited by 455
Respiratory Syncytial Virus Infection in Adults
Falsey, A. R., & Walsh, E. E. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.371 · Cited by 438
Karron, R. A., Buonagurio, D. A., Georgiu, A. F., Whitehead, S. S., Adamus, J. E., Clements-Mann, M. L., Harris, D. O., Randolph, V. B., Udem, S. A., Murphy, B. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13961 · Cited by 420
Self-citationSimoes, E. A. F. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00511-0 · Cited by 402
Respiratory Syncytial Virus: Virology, Reverse Genetics, and Pathogenesis of Disease
Collins, P. L., Fearns, R., & Graham, B. S. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-38919-1_1 · Cited by 380
Wright, P. F., Karron, R. A., Belshe, R. B., Thompson, J., Crowe, Jr., Boyce, T. G., Halburnt, L. L., Reed, G. W., Whitehead, S. S., Anderson, E. L., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315859 · Cited by 307
Self-citationKarron, R. A., Wright, P. F., Belshe, R. B., Thumar, B., Casey, R., Newman, F., Polack, F. P., Randolph, V. B., Deatly, A., Hackell, J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427813 · Cited by 287
Self-citationRespiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment
Domachowske, J. B., & Rosenberg, H. F. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.298 · Cited by 260
Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease
WALSH, E. E., FALSEY, A. R., & HENNESSEY, P. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9901004 · Cited by 187
Respiratory syncytial virus vaccine development
Crowe, J. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00287-0 · Cited by 70
Vaccines against human respiratory syncytial virus in clinical trials, where are we now?
Rossey, I., & Saelens, X. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1675520 · Cited by 32
Metadata
- Authors
- Karron, R. A., Wright, P. F., Crowe, Jr., Clements‐Mann, M. L., Thompson, J., Makhene, M., Casey, R., & Murphy, B. R.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-12
- Volume
- 176
- Issue
- 6
- Pages
- 1428-1436
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2122557423
- Cited by
- 208
- References
- 2
- FWCI
- 14.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.